RxDoctor Payments Data

Charles Bramlett, MD

Anatomic Pathology & Clinical Pathology · Columbia, TNNPI 1518903632

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 32.2% of the total. Reporting peaked in 2024 at $49 and has fallen 58.3% since, to $21 in 2025.

$153in general payments, 2019–2025

Across 8 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironshore Pharmaceuticals Inc.$49
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$41
  • Beckman Coulter, Inc.$31
  • Roche Diagnostics Corporation$19
  • Siemens Medical Solutions USA, Inc.$13
$25,000in research payments, 2019–2025

Across 1 payment — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Diagnostica Stago, Inc$25K

What the payments were for

  • Food & beverage$153100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$153 in reported general payments places this provider in the 65th percentile of 234 anatomic pathology & clinical pathology providers in Tennessee.

See all anatomic pathology & clinical pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$67,259
Medicare patients
483
Services billed
1,970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Columbia

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →